Table 2.
Diagnostic methods
| Disease pattern | Direct vs indirect | Diagnostic method | Comments |
|---|---|---|---|
| Cutaneous leishmaniasis | Direct | Biopsy, scraping, aspirate | Sensitivity dependent on expertise of pathologist and quality of specimen. Obtain from edge of ulcer and base |
| Microscopy | Giemsa stained microscopy | ||
| Culture | Amastigote typically 2–4 μm in diameter, round to oval in shape with nucleus and kinetoplast | ||
| Histology | Special media, as organism is fastidious it can take weeks to become positive. | ||
| PCR | Most sensitive, identifies species which is helpful in excluding ML associated species. PCR is also helpful in cases with low parasite burden. | ||
| Indirect | CL Detect | Immunochromatographic assay for the rapid detection of Leishmania species antigen in ulcerative skin lesions | |
| Sensitivity 96%, specificity 90% | |||
| Serologic tests (see below) | Not recommended for diagnosis of CL | ||
| Visceral leishmaniasis | Direct | Splenic aspirate (parasite isolation, culture, histology, and PCR per above) | Most sensitive (93–99%) compared to bone marrow and lymph node aspirate for diagnosing VL but risk of splenic hemorrhage |
| Bone marrow aspirate | Bone marrow sensitivity (52–85%) sensitivity. | ||
| Safer to perform than splenic aspirate | |||
| LN Aspirate | Lymph node aspirate sensitivity (52%–58%) | ||
| Peripheral blood | Assess blood for buffy coat, in vitro culture, and molecular analyses. Helpful in diagnosis for immunocompromised and HIV | ||
| Indirect | Serological tests: | Cannot distinguish active from prior infection. Not helpful for CL. Often non-reactive in immunocompromised hosts. | |
| Rapid Diagnostic Test (rK-39)* | Detect specific antibody against antigen present in L. donovani, chagasi-infantum | ||
| Results available in 20–25 min | |||
| Easy to perform, quick and cheap- particularly helpful in underserved areas | |||
| Sensitivity varies depending on region and parasite species | |||
| Can cross react with other infections—for example Chagas disease | |||
| Direct Agglutination Test (DAT)* | Uses whole organisms to look for antibody. | ||
| Gives antibody tires ranging from 1:100 up to 1: 151200. | |||
| Sensitive (>95%) and specific (>85%) test when performed correctly | |||
| Needs well trained technician to perform over 2-3 days | |||
| Not available in North America | |||
| Other antibody test, ELISA, Indirect immunofluorescence, indirect agglutination test, antigen test | Serologic antigen and urine antigen available | ||
| Sensitivity and specificity varies based on test | |||
| False positive results in persons with Chagas, leprosy, tuberculosis, malaria | |||
| Mucosal leishmaniasis | Direct | Biopsy, scraping, aspirate of mucosal lesion/LN (culture, histology, and PCR per above) | Direct diagnosis is preferred. |
| Indirect | Serological tests per above | Not as helpful for ML as for VL. Direct diagnosis is preferred | |
| Leishmanin Test | Delayed type hypersensitivity response | ||
| Also known as Montenegro test, works similarly to tuberculin skin test | |||
| Most useful in diagnosis of ML | |||
| Negative in diffuse CL, active VL | |||
| False positives with other skin disease | |||
| Not available in North America |
CL, cutaneous leishmaniasis; ML, mucosal leishmaniasis; VL, visceral leishmaniasis; LN, lymph node
*Most common serological tests
Adapted from Aronson et al. CID, PAHO, Burza et al., Berman et al.